Truth About Weight Loss Drugs

Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.
The Truth About Weight Loss Drugs
Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or tirzepatide is right for you.
Women turn to weight loss drugs in menopause: What to know about the benefits and risks
Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, according to Shepherd. The average age for menopause, when your periods stop permanently, is 52, according to the U.S. Office on Women's Health. Menopause is reached after it has been a full year since your last period.
Weight-loss drugs didn't curb health costs within two years
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims shared with Reuters.
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects
Competition will make weight-loss drugs better, cheaper and bigger
A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has offered its own version of Wegovy,
Big Food Is Learning to Love Weight-Loss Drugs
A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present just as many opportunities as pitfalls. People taking the drugs do indeed eat less—especially indulgent treats.
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new tally finds. "In contrast, there was a 25.6% decrease in patients undergoing metabolic bariatric surgery" during the same time period,
Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity
A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023.
Rolling Out15m
7 amazing things nobody tells you about semaglutide weight loss results
Looking to drop those stubborn pounds? The weight loss world is buzzing about a game-changing medication that's helping ...
Bariatric surgeries drop sharply as people turn to Wegovy, Saxenda for weight loss
The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...
'Lazy' weight loss tips will help you shed pounds with no diet or gym membership
A weight loss expert has shared her tips on how to lose weight for 'lazy' people, and she says you don't need to go to the ...
Rolling Out2h
7 crucial facts about Ozempic’s controversial rise in weight loss treatment
The increasing use of Ozempic for modest weight loss has sparked intense debate within medical communities, raising questions ...
7 Most Effective Cable Machine Exercises for Weight Loss
Attach a rope or straight bar to the cable machine and adjust the weight. Stand tall, feet shoulder-distance apart, facing ...
The Best Weight Loss Gummies to Burn Fat Safely & Naturally
While many people think attaining healthy weight loss is as easy as eating a balanced diet and engaging in regular physical ...
Weight-loss jabs are not ‘to get a body beautiful picture for Instagram’, says Wes Streeting
Weight-loss jabs are not a quick fix for an “Instagram body”, the Health Secretary has warned. The medicines regulator has ...
ScienceAlert on MSN1d
Boosting Access to Weight-Loss Drugs Could Save Thousands of Lives
The lives of Americans could be dramatically improved, and in thousands of cases even saved, by increasing access to ...